Allowable error | Unit | Decided methods | |
---|---|---|---|
pH | ±0.04 | CLIA performance criteria | |
PCO2 | ±5 | mmHg | CLIA performance criteria |
PO2 | ±7 | mmHg | CLIA performance criteria |
HCO3 | ±1.6 | mmol/L | {(ULN 26) − (LLN 22)} × 0.4 |
Na | ±4 | mmol/L | CLIA performance criteria |
K | ±0.5 | mmol/L | CLIA performance criteria |
Ca | ±0.08 | mmol/L | {(ULN 1.35) − (LLN 1.15)} × 0.4 |
Hb | ±1.12 | g/dL | CLIA performance criteria |
Ht | ±3 | % | CLIA performance criteria |
SO2 | ±1.6 | % | {(ULN 99) − (LLN 95)} × 0.4 |
BE | ±1.6 | mmol/L | {(ULN 2) − (LLN −2)} × 0.4 |
Variables | |
---|---|
Age, years | 72 ± 14.5 |
Male, N | 75% |
BMI, kg/m2 | 24 ± 12.4 |
Smoking, N | 65% |
SBP, mmHg | 122 ± 28.9 |
HTN, N | 70% |
DM, N | 60% |
Anemia, N | 40% |
Hb, N | 12.5 ± 1.95 |
CKD, N | 25% |
COPD, N | 30% |
Malignancy, N | 10% |
Ventilator, N | 20% |
Antiplatelet therapy, N | 40% |
Anticoagulation therapy, N | 10% |
Plt, ×104/μL | 18.8 ± 5.8 |
PT-INR | 1.10 ± 0.11 |
Cause of admission | |
Heart disease, N | 55% |
Lung disease, N | 25% |
Infectious disease, N | 15% |
Others, N | 5% |